4-Bromo-1-(2-hydroxyethyl)pyridin-2(1H)-one, 98%, 5g

5-(4-(Diphenylamino)phenyl)thiophene-2-carbaldehyde, 97%, 1g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 60, 500 ml, 90 mm, 1 Piece

N-(2,6-DICHLOROBENZOYL)-4-(2,6-DIMETHOXYPHENYL)-L-PHENYLALANINE, 95%, 10mg

1-{[4-(Acetylamino)phenyl]sulfonyl}piperidine-2-carboxylic acid, 95.0%, 250mg

2-Chloro-4,6-dimethyl-1,3,5-triazine, 97%, 250mg

2,4,5-Trifluoro-1,3-phenylenediamine>98.0%(T)5g

TERT-BUTYL 4-(2-((TERT-BUTOXYCARBONYL)AMINO)-3-METHOXY-3-OXOPROPYL)-1H-IMIDAZOLE-1-CARBOXYLATE, 95.0%, 5g

4-Methyloxan-4-amine, 97%, 5g

ethyl 5-amino-3-methylthiophene-2-carboxylate hydrochloride, 95.0%, 500mg

Diethyl 2,2-diethylmalonate, 95.0%, 500g

Ethyl 4-oxotetrahydro-2H-pyran-3-carboxylate, 95.0%, 250mg

GC capillary column ROTI®Cap-624, 50 m, 0.25 mm, 1.40 µm, 1 Piece(s)